World Alloimmunization and HDFN Awareness day 2025
New Screening Opportunity for RhD Negative and Alloimmunized Pregnant Individuals
March 12 marks World Alloimmunization and Hemolytic Disease of the Fetus and Newborn (HDFN) Awareness Day, a global initiative to increase awareness and advocate for patients impacted by, and providers managing, Alloimmunization and HDFN.
| Ontario is making significant progress in this area with the implementation of two new screening tests to assess for fetal blood group incompatibility in pregnancy. This advancement will enhance prenatal care by offering timely information to support the decision-making of health-care providers and their patients. |
What You Need to Know
Have questions? Find out:
✔ What tests will be available?
✔ Who is eligible for testing?
✔ What benefits are provided by this test?
Subscribe
Back to News Search
Contact Us
Prenatal Screening Ontario
CHEO Research Institute
Centre for Practice-Changing Research Building
401 Smyth Road
Ottawa, ON K1H 8L1
Information line
Phone: 613-737-2281
Toll-Free: 1-833-351-6490
Monday to Friday, 9:00 AM to 3:00 PM EST
Subscribe to PSO Updates
Subscribe to stay informed with the latest PSO news and prenatal screening updates in Ontario.